West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:02:11 2026-08-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 337.47 USD | -2.49% |
|
-4.42% | +22.65% |
| Aug. 26 | Boston Scientific hit by cyberattack, global operations affected | RE |
| Aug. 03 | Is everything under control? |  |
| Market Cap | 23.75B 20.47B 19.19B 17.52B 33B 2,270B 33.1B 228B 88.82B 1,146B 89.17B 87.23B 3,799B | P/E 2026 * |
39.4x | P/E 2027 * | 34.2x |
|---|---|---|---|---|---|
| Enterprise Value | 23.25B 20.03B 18.78B 17.14B 32.3B 2,222B 32.4B 223B 86.94B 1,122B 87.28B 85.38B 3,719B | EV / Sales 2026 * |
6.89x | EV / Sales 2027 * | 6.33x |
| Free-Float |
92.89% | Yield 2026 * |
0.27% | Yield 2027 * | 0.29% |
Last Transcript : West Pharmaceutical Services, Inc.
| Aug. 26 | West to Participate in Upcoming Investor Conferences | PR |
| Jul. 23 | West Pharmaceutical: Q2 Earnings Snapshot | AQ |
| Jul. 23 | West Reports Second-Quarter 2026 Results | PR |
| Jul. 21 | West Declares Quarterly Dividend | PR |
| Jul. 07 | West to Host Second-Quarter 2026 Conference Call | PR |
| 1 day | -2.49% | ||
| 1 week | -4.42% | ||
| Current month | -1.02% | ||
| 1 month | +0.14% | ||
| 3 months | +4.87% | ||
| 6 months | +32.68% | ||
| Current year | +22.65% |
| 1 week | 336.13 |  | 354.78 |
| 1 month | 334.36 | | 360.28 |
| Current year | 223.83 | | 386 |
| 1 year | 223.83 | | 386 |
| 3 years | 187.43 | | 415.73 |
| 5 years | 187.43 | | 475.35 |
| 10 years | 70.17 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 56 | 2015-04-23 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/11/26 | Fiscal year | Chief Financial Officer | 17,408 | 0.0247% | ||
| 6/30/26 | Other | Director | 46 | 0.0001% | ||
| 5/12/26 | Fiscal year | Executive/Senior Manager | 1,759 | 0.0025% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.49% | -4.42% | +37.49% | -16.34% | 23.75B | |
| +0.79% | -3.58% | -14.39% | +9.42% | 195B | |
| +1.40% | -2.27% | -0.79% | +12.09% | 117B | |
| +0.25% | +1.25% | +11.09% | +78.52% | 61.45B | |
| -0.25% | -1.97% | +26.78% | +53.11% | 51.03B | |
| +0.74% | -1.29% | -0.90% | -32.69% | 51.62B | |
| +1.71% | -1.65% | +20.96% | -8.53% | 34.27B | |
| +1.82% | +2.98% | - | - | 30.95B | |
| -0.82% | -1.17% | -4.66% | +18.23% | 23.41B | |
| +0.35% | -1.74% | -4.49% | +2.61% | 22.79B | |
| Average | +0.35% | -1.10% | +7.90% | +12.94% | 61.07B | |
| Weighted average by Cap. | +0.66% | -1.84% | +0.87% | +15.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.37B 2.91B 2.73B 2.49B 4.69B 323B 4.7B 32.35B 12.62B 163B 12.67B 12.39B 540B | 3.59B 3.09B 2.9B 2.65B 4.98B 343B 5B 34.38B 13.42B 173B 13.47B 13.17B 574B |
| Net income | 615M 530M 497M 453M 854M 58.73B 857M 5.89B 2.3B 29.65B 2.31B 2.26B 98.31B | 701M 604M 567M 517M 974M 67.02B 977M 6.72B 2.62B 33.83B 2.63B 2.58B 112B |
| Net Debt | -503M -434M -407M -371M -699M -48.1B -701M -4.82B -1.88B -24.28B -1.89B -1.85B -80.51B | -1.04B -895M -840M -766M -1.44B -99.31B -1.45B -9.96B -3.89B -50.13B -3.9B -3.82B -166B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | $337.47 | -2.49% | 496,342 |
| 26-08-27 | $346.09 | -1.09% | 365,990 |
| 26-08-26 | $349.92 | +0.41% | 440,221 |
| 26-08-25 | $348.48 | -1.37% | 383,760 |
| 26-08-24 | $353.32 | +0.07% | 473,305 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
